Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study

被引：0
|
作者：
Svenja K. Deuchler
Ralf Schubert
Pankaj Singh
Adonis Chedid
Ninel Kenikstul
Julia Scott
Thomas Kohnen
Hanns Ackermann
Frank Koch
机构：
[1] Augenzentrum Frankfurt,Department of Ophthalmology
[2] Goethe University Hospital,Pneumological
[3] Goethe University Hospital,Immunological Laboratory
[4] Goethe University Hospital,Institute of Biostatistics
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2022年 / 260卷
关键词：
Cytokines; Diabetic macular edema; Diabetic retinopathy; Fluocinolone acetonide; Growth factors; Inflammatory markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2537 / 2547
页数：10
相关论文
共 50 条
  • [31] Optical Coherence Tomography Biomarkers: Vitreous Status Influence in Outcomes for Diabetic Macular Edema Therapy with 0.19-mg Fluocinolone Acetonide Implant
    Pessoa, Bernardete
    Ferreira, Andre
    Leite, Joao
    Figueira, Joao
    Meireles, Angelina
    Beirao, Joao Melo
    OPHTHALMIC RESEARCH, 2021, 64 (04) : 639 - 647
  • [32] IS THE DIABETIC MACULAR EDEMA CHRONICITY A PROGNOSTIC FACTOR FOR FUNCTIONAL AND ANATOMIC OUTCOMES IN PATIENTS TREATED WITH 0.19 MG FLUOCINOLONE ACETONIDE IMPLANT?
    Meireles, Angelina
    Coelho, Joao
    Silva, Nisa
    Marta, Ana
    Beirao, Joao
    Pessoa, Bernardete
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [33] The efficacy and safety outcomes of the 0.19 mg fluocinolone acetonide implant after prior treatment with the 0.7 mg dexamethasone implant in patients with diabetic macular edema
    Singh, P.
    Chedid, A.
    Deuchler, S. K.
    Kohnen, T.
    Mueller, M.
    Koch, F. H.
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2018, 11 : 265 - 269
  • [34] Real-world clinical outcomes after sustained delivery of the 0.19 mg fluocinolone acetonide (FAc) implant for treatment of diabetic macular edema (DME)
    Godel, Sarah
    Oncel, Damla
    Donkor, Richard
    Coney, Joseph M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [35] 36-months real-world experience in patients with refractory chronic diabetic macular edema (DME) treated with the 190 micrograms fluocinolone acetonide intravitreal implant (ILUVIEN).
    Putri, Christine Anggun
    Quhill, Fahd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [36] Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome
    Marques, Joao Heitor
    Abreu, Ana Carolina
    Silva, Nisa
    Meireles, Angelina
    Pessoa, Bernardete
    Beirao, Joao Melo
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 127 - 132
  • [37] Fluocinolone acetonide intravitreal implant in patients with diabetic macular edema: 12 month results
    Pearson, P
    Baker, CW
    Eliott, D
    Ip, MS
    Morse, LS
    Callanan, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U489 - U489
  • [38] Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema The PALADIN Study
    Singer, Michael A.
    Sheth, Veeral
    Mansour, Sam E.
    Coughlin, Brandon
    Gonzalez, Victor H.
    OPHTHALMOLOGY, 2022, 129 (06) : 605 - 613
  • [39] Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
    McCluskey, Jessica D.
    Kaufman, Paul L.
    Wynne, Kathy
    Lewis, Gregory
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2019, 12 : 93 - 102
  • [40] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
12345